An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

Cancer Journal

Volumn 10, Issue 5, 2004, Pages 294-300

  Martel, Cynthia L ^a,b   Li, Yueju ^a,c   Beckett, Laurel ^a,c   Chew, Helen ^a,b   Christensen, Scott ^a,b   Davies, Angela ^a,b   Lam, Kit S ^a,b   Lau, Derick H ^a,b   Meyers, Frederick J ^a,b   O'Donnell, Robert T ^a,b   Richman, Carol ^a,b   Scudder, Sidney ^a,b   Tanaka, Michael ^a,b   Tuscano, Joseph ^a,b   Welborn, Jeanna ^a,b   Wun, Theodore ^a,b   Gandara, David R ^a,b   Lara Jr , Primo N ^a,b  

^a University of California Davis Cancer Center ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Accrual; Barriers to enrollment; Clinical trials

Indexed keywords

ARTICLE; CANCER; CANCER CENTER; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEMOGRAPHY; HEALTH SURVEY; HUMAN; INSURANCE; LAW; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES; ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOL; FEMALE; HEALTH INSURANCE; LEGAL ASPECT; MALE; MIDDLE AGED; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PATIENT SELECTION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; REFUSAL TO PARTICIPATE; REIMBURSEMENT; RESEARCH SUBJECT; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CLINICAL PROTOCOLS; CLINICAL TRIALS; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; REFERRAL AND CONSULTATION; REFUSAL TO PARTICIPATE; RESEARCH SUBJECTS;

EID: 16644366286     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200409000-00006     Document Type: Article

References (8)

1. Sateren WB, Trimble EL, Abrams J et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-2117.
2. Stiller C. Centralised treatment, entry to trials, and survival. Br J Cancer 1994;70:352-362.
3. Ehrlich PF, Newman KD, Haase GM et al. Lessons learned from a failed multi-institutional randomized controlled study. J Pediatr Surg 2002;37:431-436.
4. Haidich AB, Ioannidis JP. Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol 2001;154:873-880.
5. Comis RL, Aldigé CR, Stovall EL et al. A quantitative survey of public attitudes towards cancer clinical trials. http://www .cancertrialshelp. org/cnccg_info/news.html. (Accessed 8/30/02.)
6. Comis RL, Miller JD, Aldigé CR et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-835.
7. Lara Jr PN, Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733.
8. Bennett CL, Adams JR, Knox KS et al. Clinical trials: are they a good buy? J Clin Oncol 2001;19:4330-4339.